Annuska M Glas

MammaPrint and BluePrint Molecular Diagnostics using targeted RNA Next-Generation Sequencing technology.

René Bernards, Jiang Chen, Lorenza Mittempergher, 2019, The Journal of molecular diagnostics : JMD.

Biological Functions of the Genes in the Mammaprint Breast Cancer Profile Reflect the Hallmarks of Cancer

Annuska M Glas, Paul Roepman, L. V. van't Veer, 2010, Biomarker insights.

Performance characteristics of the MammaPrint® breast cancer diagnostic gene signature.

Diederik Wehkamp, Annuska M Glas, L. V. van't Veer, 2013, Personalized medicine.

Robust interlaboratory reproducibility of a gene expression signature measurement consistent with the needs of a new generation of diagnostic tools

Anya Tsalenko, Arno Floore, Fatima Cardoso, 2007, BMC Genomics.

Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.

Arno Floore, Daphne de Jong, Anke Witteveen, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

Wim H van Harten, Valesca P Retel, Guido Brink, 2007, The Lancet. Oncology.

Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.

Philip M Kluin, Leonie Delahaye, Daphne de Jong, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gene expression profiles of primary breast tumors maintained in distant metastases

Annuska M Glas, J. Peterse, A. Witteveen, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment.

Peter Joosten, Philip M Kluin, René Bernards, 2005, Blood.